News
GLP-1 drugs fueled a jump in R.I. health care spending, nearly tripling in three years, report finds
The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.
Donald Trump recently made fun of his friend who takes Ozempic, adding that the weight-loss drug doesn’t seem to be working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results